patent/TR-201820816-A2

Predicate	Object
assignee	http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c36674ae429b5ddb4544bd4d892483e3
classificationCPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-496 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-19
filingDate	2018-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor	http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ba444a3993e28d65121c05bcd712b243
publicationDate	2020-07-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber	TR-201820816-A2
titleOfInvention	STABLE INJECTABLE POSACONAZOL FORMULATIONS CONTAINING CYCLODEXTRINE AND SUGAR
abstract	The present invention relates to stable injectable formulations containing the active ingredient posaconazole as well as cyclodextrin and sugar as excipients, and the use of these formulations in the treatment of invasive infections caused by Candida, Aspergillus, derivatives of fungi.
priorityDate	2018-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type	http://data.epo.org/linked-data/def/patent/Publication

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419561012 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID468595

Total number of triples: 18.